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Since the development of the first genetically engi-
neered (GE) plants and animals for agriculture almost
25 years ago (Hammer et al. 1985; Vaeck et al.
1987), there has been a debate amongst and between
scientists, regulators, and activists opposed to the
introduction and use of such plants and animals in
agriculture. It seems that the debate often focuses on
GE as a technique that is used in isolation, rather than
one tool in the realm of selective breeding that is used
in conjunction with other approaches such as nutri-
tional management, veterinary care, and animal
management to solve problems. The ongoing debate
has shaped international policy, resulted in numerous
reviews (e.g. Wall et al. 2009), reports (e.g. FAO/
WHO Expert Consultation 2004; Royal Society 2001;
NRC 2002, 2004), and regulations by national and
international bodies (FAO/WHO Food standards
programme codex alimentarius commission 2008;
FDA-CVM 2009), and delayed the introduction of
GE animals into agriculture. The debate usually
raises the same list of risks or concerns, including
animal welfare, loss of genetic diversity in production
animals, ‘‘un-naturalness’’, food safety including
potential toxicity or allergenicity, environmental
damage following release, and un-intended conse-
quences such as activation of quiescent viruses or
inappropriate gene expression resulting from activa-
tion of endogenous genes by the transgene. However,
one concept missing from this debate is the cost of
not using this technology to benefit agriculture and
thus human lives; that is, the positive components of
the risk benefit analysis. Here, the above mentioned
risks will be briefly summarized, as they have been
covered in depth in many reports and reviews (e.g.
NRC 2002), and examples of what we have to lose if
GE animals are not adopted will be presented.
The potential risks of GE animals
First, the concerns about animal welfare and loss of
genetic diversity are general issues for all domesti-
cated food animals, and as such, are not unique to the
production and use of GE animals. While the
expression of some genes, such as growth hormone
(GH) in mammals, did result in adverse affects on the
well-being of the GE mammals (Pursel et al. 1990;
Nancarrow et al. 1991), such work has been discon-
tinued. The loss of genetic diversity, for example in
dairy cattle breeds or many agronomically important
crops, is a function of the success of selective
breeding coupled with economic considerations, and
is not unique to GE, nor caused directly by being GE.
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The concept of un-naturalness is related to faith
and belief systems, and as such is not subject to
scientific debate. Individuals objecting to GE animals
based on their belief system are also likely to object
to artificial insemination, embryo transfer, and/or
cloning, as well as other technologies on the contin-
uum of animal breeding.
Food safety issues may be of legitimate concern
and as such must be assessed on a case-by-case basis,
as new proteins may be allergenic or toxic. In such
cases, protocols have been developed to determine
the potential risk of a new protein, for example as
outlined in the Codex Alimentarius (FAO/WHO
Food standards programme codex alimentarius com-
mission 2008). While plants contain many toxic
compounds, whose expression and therefore concen-
tration could possibly be affected by the nearby
integration of a transgene, agriculturally important
mammals, poultry and fish (for the most part) do not
naturally express toxins and thus this is not a concern
for GE animals. However, many animals do express
proteins that are allergens for some individuals and
the expression of the genes encoding these proteins
could potentially be altered by transgene integration
or expression, as well as by mutations, although the
probability is slight.
The risk of environmental damage resulting from
the release of GE animals, particularly fish, is again a
legitimate concern and was noted in one NRC (2002)
report as perhaps the most significant risk associated
with GE food animals. These risks will need to
assessed on a case-by-case basis with consideration
given to the species involved, the specific nature of
the transgene construct used and its resulting product,
and the environment in the area where release might
occur.
Perhaps the most difficult risks to assess are those
labeled as ‘‘un-intended consequences’’, as they are
non-specific and usually are assumed to be adverse or
potentially harmful. As the scientific method can not
be used to prove a negative, we need to look to our
past experience to assess the potential risk. Three
observations help to put this risk category into
perspective. First, throughout the course of human
evolution people have eaten virtually all develop-
mental stages of most common animals, birds and
fish and therefore have consumed virtually all
products from the genes in these animals, including
quiescent viral sequences.
Second, horizontal gene transfer in the absence of
transposable elements or viral vectors is exceedingly
rare, if it occurs at all, in higher eukaryotes. We do
after all eat the DNA of all food species we consume
each day, together with the accompanying bacterial
and viral DNA sequences, yet we do not take up and
incorporate functional genes from our food.
Third, we have gained considerable experience
with eating GE plants over the last 15 years. To date
there has only been one report of an un-intended
consequence from eating a GE plant, namely BT-corn.
In this instance the consequence is positive in that BT-
corn suffers less insect damage and thereby incurs
fewer incidences of fungal infection. This results in
the amount of fumonisin, a highly toxic fungal
mycotoxin, being reduced by up to 15-fold in BT-
corn (Wu 2006). Fumonisin poisoning is associated
with a number of human health concerns including
increased incidences of esophageal and liver cancer,
still-births, and neurological developmental defects
(e.g. spinal bifida) in newborns. The link to birth
defects is so striking that a very strong case can be
made that scientists and health professionals should
strongly advocate that pregnant women, particularly
in the developing world where food safety standards
are much lower, should consume only BT-corn.
Combined, these observations suggest that the risk
of a significantly negative adverse effect from the use
of GE animals for food is fairly unlikely, particularly
with the requirements for premarket approval, which
among other things assesses the likelihood that the
transgene product may be toxic or allergenic (e.g.
FDA-CVM 2009).
The risk of not using GE animals
All of the above risks of using GE animals have been
thoroughly discussed and examined, both in the
scientific literature as well as the popular press.
However, the risks, or cost, to human welfare from
not using GE livestock, poultry and fish have yet to
be addressed. GE animals are not the answer to all
production or food quality problems, but there are
clear areas where a GE approach can contribute to
solving a specific problem where the more traditional
approaches can not. GE of an animal is not carried
out in isolation from other approaches used in animal
agriculture, but rather is used in conjunction with
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selective breeding, veterinary intervention, nutrition,
and animal management techniques. GE, or any other
approach, does not need to completely solve a
problem in order to be worthwhile. It simply means
that the use of GE could make a positive difference in
some situations and that there is a cost to human
society when a technology that can contribute to
solving a problem is not used. To illustrate this point,
three examples will be outlined as each has, to
varying degrees, been validated. The first deals with
increasing animal production in the face of an
increasing demand for food, the second contributes
to the mitigation of the impact of animal production
on surface water eutrophication, and the third
proposes to use GE animals to decrease the effects
of debilitating diarrhea in the developing world.
First, the human population is steadily increasing
and is predicted to rise to over 9 billion people by
2050 (UN: Population Division of the Department of
Economic and Social Affairs of the United Nations
Secretariat, World Population Prospects: The 2008).
Wheeler and colleagues have produced a line of GE
pigs that express bovine a-lactalbumin in the mam-
mary gland, which leads to an increase in milk
production, and consequently results in the successful
weaning of more baby pigs per litter on average
(Wheeler et al. 2001). This is a positive effect both in
terms of animal welfare, in that more of the baby pigs
born survive to weaning, and in terms of increasing
the efficiency of production at a time when world
population and demand for protein is steadily
increasing.
Second, consider the EnviroPigTM, a line of pigs
genetically engineered to express an E. coli phytase
gene in the salivary gland in response to concerns about
phosphorus utilization (Golovan et al. 2001) and the
effects of swine production on surface water eutrophi-
cation, a growing environmental problem across the
developed and developing world. The EnviroPigTM
line of animals can obtain all its required phosphorous
from consumed plant material and thus does not
require rations to be supplemented with non-organic
phosphate, with the result that fecal phosphorus is
significantly reduced. This results in animals with a
significantly decreased impact on the environment,
thereby increasing the sustainability of production.
Finally, milk from our human lysozyme transgenic
goats (Maga et al. 2006a) has several potential
benefits, including improved udder health, increased
shelf-life of the milk, and increased gastrointestinal
health of young animals or humans consuming the
milk. Milk from the transgenic goats contains
approximately 1,000 times more lysozyme than
non-modified goats’ milk, which is approximately
65% of the lysozyme found in normal human milk.
This milk has antimicrobial properties, both in vitro
(Maga et al. 2006b) and when consumed by animal
models, even after pasteurization (Brundige et al.
2008). Although we have not yet tested this milk in
humans, our data indicate that all the potential
benefits are likely to be achieved, including the
gastrointestinal benefits for humans. According to the
WHO, over 2 million children die yearly from
diarrheal diseases, with E. coli being one of the
major causative organisms, bacteria whose growth
and viability is clearly inhibited in vivo with the
consumption of human lysozyme-containing goats’
milk by young pigs.
GE animals can contribute to agriculture
in the future
Each of the above examples has been shown to be
potentially effective at addressing an identified prob-
lem and in each case the problem could not have been
as efficiently addressed by a traditional animal
breeding approach. That is not to say that a GE
approach is the only possible solution or that GE
alone solves the problem, but rather that by using a
GE approach a significant part of the problem can be
addressed. Furthermore, data now exist for each of
the above examples, and for other GE animals
including milk cows (Laible et al. 2007), tilapia
(Caelers et al. 2005), and salmon (Devlin et al. 2009),
to show that GE animals can be routinely produced
that are healthy, normal individuals. In each case, the
expressed transgene has been shown to function as
predicted and to confer a new trait or property to the
animal, e.g. the ability to digest phytate, or to
improve a natural trait beyond what could have
reasonably been achieved by a traditional breeding
approach. Perhaps most significantly, each of these
lines of transgenic animals has been shown to have
normal growth and reproductive parameters for their
respective species and, in this regard, are no different
from any other animals used in current production
systems. In summary, we have demonstrated that we
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can use GE to add to the already considerable genetic
variability that exists in our domestic animals through
natural mutations and to address some of the
significant problems that will face animal agriculture
and the growing human population in the future.
The issue before us now is not whether we can
safely GE our animals for specific and worthy
purposes, but rather will such animals be allowed
into the food chain and be accepted by the consumer.
At this point we need to ask ourselves what will be
lost if we do not use GE animals? Using the examples
discussed above, do we choose not to use GE pigs
and maintain less sustainable food production sys-
tems that harm the environment while producing
inadequate amounts of food for the growing popula-
tion? Do we ignore human health problems that can
be uniquely addressed by GE by waiting, possibly
futilely, for a more ‘‘conventional’’ solution over a
longer time frame? Perhaps even more importantly
we need to ask ourselves what are the risks, or costs,
to the environment, animal welfare, and human
health if GE animals are not used. Consider the
possibility of using knock-out technology to end the
threat of prion diseases such as mad-cow disease or
scrapie as demonstrated by Richt et al. (2007) and the
potential benefit to both the animals and humans.
While there is no doubt that the risks of all new
technologies must be investigated and mitigated,
most of the GE animal applications currently being
pursued have been well-characterized. This leads us
to conclude that there is no question that there is a
cost associated with not applying this technology in
terms of lost opportunities to contribute to solving
some of the major problems facing animal agriculture
and feeding a growing world.
In summary, before introducing a GE animal into
the agricultural production system it certainly is
necessary to consider the risks, but this has to be a
true risk benefit analysis that fairly weighs the risk, if
any, of the GE-introduced change against the
potential benefits of that change and the cost to the
consumer, the producer, the environment and to the
animals themselves if that GE line is not used.
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